275 related articles for article (PubMed ID: 23769790)
21. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
[TBL] [Abstract][Full Text] [Related]
22. Atypical transient subretinal exudation following photodynamic therapy for chronic central serous retinopathy: a case report.
Al-Awadi A; Mandelcorn ED; Somani S
Can J Ophthalmol; 2017 Feb; 52(1):e38-e41. PubMed ID: 28237171
[No Abstract] [Full Text] [Related]
23. The efficacy of intravitreal bevacizumab for idiopathic central serous chorioretinopathy.
Lim JW; Kim MU
Graefes Arch Clin Exp Ophthalmol; 2011 Jul; 249(7):969-74. PubMed ID: 21140161
[TBL] [Abstract][Full Text] [Related]
24. Multimodal imaging for the diagnosis of an atypical case of central serous chorioretinopathy.
Kahloun R; Chebbi A; Amor SB; Ksiaa I; Nacef L; Khairallah M
Middle East Afr J Ophthalmol; 2014; 21(4):354-7. PubMed ID: 25371645
[TBL] [Abstract][Full Text] [Related]
25. Serous retinal detachment after panretinal photocoagulation for proliferative diabetic retinopathy: a case report.
Schatz P; Aldayel A; Taskintuna I; Abdelkader E; Mura M
J Med Case Rep; 2017 Sep; 11(1):265. PubMed ID: 28923115
[TBL] [Abstract][Full Text] [Related]
26. Repeated intravitreal bevacizumab injection with and without macular grid photocoagulation for treatment of diffuse diabetic macular edema.
Solaiman KA; Diab MM; Dabour SA
Retina; 2013 Sep; 33(8):1623-9. PubMed ID: 23538584
[TBL] [Abstract][Full Text] [Related]
27. Intravitreal bevacizumab to treat acute central serous chorioretinopathy: short-term effect.
Seong HK; Bae JH; Kim ES; Han JR; Nam WH; Kim HK
Ophthalmologica; 2009; 223(5):343-7. PubMed ID: 19521133
[TBL] [Abstract][Full Text] [Related]
28. Optical coherence tomography-measured pigment epithelial detachment height as a predictor for retinal pigment epithelial tears associated with intravitreal bevacizumab injections.
Chan CK; Abraham P; Meyer CH; Kokame GT; Kaiser PK; Rauser ME; Gross JG; Nuthi AS; Lin SG; Daher NS
Retina; 2010 Feb; 30(2):203-11. PubMed ID: 19952998
[TBL] [Abstract][Full Text] [Related]
29. A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study.
Pitcher JD; Witkin AJ; DeCroos FC; Ho AC
Br J Ophthalmol; 2015 Jun; 99(6):848-52. PubMed ID: 25595177
[TBL] [Abstract][Full Text] [Related]
30. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results.
Gharbiya M; Allievi F; Recupero V; Martini D; Mazzeo L; Gabrieli CB
Retina; 2009 Jun; 29(6):740-9. PubMed ID: 19516116
[TBL] [Abstract][Full Text] [Related]
31. Optical coherence tomographic angiography of choroidal neovascularization associated with central serous chorioretinopathy.
McClintic SM; Jia Y; Huang D; Bailey ST
JAMA Ophthalmol; 2015 Oct; 133(10):1212-4. PubMed ID: 26135638
[No Abstract] [Full Text] [Related]
32. Type 3 neovascularization: evolution, association with pigment epithelial detachment, and treatment response as revealed by spectral domain optical coherence tomography.
Nagiel A; Sarraf D; Sadda SR; Spaide RF; Jung JJ; Bhavsar KV; Ameri H; Querques G; Freund KB
Retina; 2015 Apr; 35(4):638-47. PubMed ID: 25650713
[TBL] [Abstract][Full Text] [Related]
33. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial.
Preti RC; Ramirez LM; Monteiro ML; Carra MK; Pelayes DE; Takahashi WY
Br J Ophthalmol; 2013 Jul; 97(7):885-9. PubMed ID: 23686001
[TBL] [Abstract][Full Text] [Related]
34. Variation in Visual Outcome to Anti-Vascular Endothelial Growth Factors in Choroidal Neovascular Membrane Developing in Eyes with Previously Untreated Versus Focal Laser-Treated Central Serous Chorioretinopathy.
Roy R; Saurabh K; Das D; Panigrahi PK; Das S; Pal SS; Jain A
Semin Ophthalmol; 2017; 32(6):781-786. PubMed ID: 27533737
[TBL] [Abstract][Full Text] [Related]
35. Repeated intravitreal bevacizumab (Avastin(®)) treatment of persistent new vessels in proliferative diabetic retinopathy after complete panretinal photocoagulation.
Schmidinger G; Maar N; Bolz M; Scholda C; Schmidt-Erfurth U
Acta Ophthalmol; 2011 Feb; 89(1):76-81. PubMed ID: 21272288
[TBL] [Abstract][Full Text] [Related]
36. Recurrent central serous chorioretinopathy after peripheral retinal laser photocoagulation: a case report.
Semeraro F; Russo A; Delcassi L; Costagliola C
Eur J Ophthalmol; 2013; 23(2):258-61. PubMed ID: 23335311
[TBL] [Abstract][Full Text] [Related]
37. BASELINE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AS A PREDICTOR OF VISUAL OUTCOME AND RECURRENCE FOR CENTRAL SEROUS CHORIORETINOPATHY.
Lee H; Lee J; Chung H; Kim HC
Retina; 2016 Jul; 36(7):1372-80. PubMed ID: 26702841
[TBL] [Abstract][Full Text] [Related]
38. Chronic central serous chorioretinopathy imaged by optical coherence tomographic angiography.
Quaranta-El Maftouhi M; El Maftouhi A; Eandi CM
Am J Ophthalmol; 2015 Sep; 160(3):581-587.e1. PubMed ID: 26133250
[TBL] [Abstract][Full Text] [Related]
39. Long-term results of intravitreal ranibizumab for the treatment of retinal angiomatous proliferation and utility of an advanced RPE analysis performed using spectral-domain optical coherence tomography.
Inoue M; Arakawa A; Yamane S; Kadonosono K
Br J Ophthalmol; 2014 Jul; 98(7):956-60. PubMed ID: 24599418
[TBL] [Abstract][Full Text] [Related]
40. Nondamaging photothermal therapy for the retina: initial clinical experience with chronic central serous retinopathy.
Lavinsky D; Palanker D
Retina; 2015 Feb; 35(2):213-22. PubMed ID: 25158944
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
